Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional

Comparison of Two Methods in the Treatment of Cytomegalovirus of the Eyes in Patients With AIDS

ClinicalTrials.gov ID: NCT00001061

Public ClinicalTrials.gov record NCT00001061. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 21, 2026, 11:44 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase II, Double-Masked, Randomized, Placebo-Controlled Evaluation of Standard Therapy vs. Standard Therapy Combined With Human Monoclonal Anti-Cytomegalovirus Antibody (MSL 109) in the Therapy of AIDS Patients With Cytomegalovirus (CMV) Retinitis

Study identification

NCT ID
NCT00001061
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
National Institute of Allergy and Infectious Diseases (NIAID)
NIH
Enrollment
167 participants

Conditions and interventions

Interventions

  • Sevirumab Drug
  • Foscarnet sodium Drug
  • Ganciclovir Drug

Drug

Eligibility (public fields only)

Age range
13 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Not listed
Primary completion
Not listed
Completion
Feb 28, 1998
Last update posted
Oct 31, 2021

Ends 1998

United States locations

U.S. sites
20
U.S. states
12
U.S. cities
16
Facility City State ZIP Site status
Alabama Therapeutics CRS Birmingham Alabama 35294
USC CRS Los Angeles California 900331079
Santa Clara Valley Med. Ctr. San Jose California 951282699
Stanford CRS Stanford California 943055107
University of Colorado Hospital CRS Aurora Colorado 80262
Univ. of Miami AIDS CRS Miami Florida 331361013
Queens Med. Ctr. Honolulu Hawaii 96816
Univ. of Hawaii at Manoa, Leahi Hosp. Honolulu Hawaii 96816
Cook County Hosp. CORE Ctr. Chicago Illinois 60612
Rush Univ. Med. Ctr. ACTG CRS Chicago Illinois 60612
Indiana Univ. School of Medicine, Infectious Disease Research Clinic Indianapolis Indiana 462025250
Massachusetts General Hospital ACTG CRS Boston Massachusetts 02114
Beth Israel Deaconess - East Campus A0102 CRS Boston Massachusetts 02215
Beth Israel Deaconess Med. Ctr., ACTG CRS Boston Massachusetts 02215
Washington U CRS St Louis Missouri
SUNY - Buffalo, Erie County Medical Ctr. Buffalo New York 14215
Univ. of Rochester ACTG CRS Rochester New York 14642
Univ. of Cincinnati CRS Cincinnati Ohio 452670405
Case CRS Cleveland Ohio 44106
Hosp. of the Univ. of Pennsylvania CRS Philadelphia Pennsylvania 19104

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00001061, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Oct 31, 2021 · Synced Jul 21, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00001061 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →